Skip to main content

Table 2 Energy expenditure and respiratory quotients of ziprasidone and olanzapine-treated patients (n = 10 per group)

From: Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study

  Ziprasidone start Ziprasidone end   Olanzapine start Olanzapine end   Ziprasidone change (%)a Olanzapine change (%)a  
Measure Median (IQR) Median (IQR) Pb Median (IQR) Median (IQR) Pb Median (IQR) Median (IQR) Pc
Absolute REE (kcal/24 hr) 1075.20 (1024.78, 1416.81) 1132.38 (1006.71, 1723.06) 0.678 1630.24 (1079.23, 1898.10) 1255.40 (1069.48, 1747.83) 0.241 1.41 (−11.98, 61.96) −5.27 (−33.37, 10.58) 0.369
REE normalized to LBM (kcal/g) 18.29 (16.68, 22.39) 24.47 (22.48, 37.13) 0.011* 27.36 (19.91, 35.36) 27.60 (23.46, 34.85) 0.445 37.78 (18.36, 83.14) 17.17 (−17.47, 36.36) 0.072
Respiratory Quotient 0.82 (0.76, 0.88) 0.84 (0.80, 0.92) 0.262 0.86 (0.81, 1.01) 0.87 (0.82, 0.92) 0.574 5.81 (−3.33, 14.40) −4.64 (−13.31, 13.27) 0.288
  1. IQR Interquartile Range, REE Resting Energy Expenditure, LBM, LBM.
  2. a, posttreatment baseline baseline * 100; b,Wilcoxon signed rank test; c, Kruskal-Wallis H test; *, p < 0.05.